Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Debt to Equity (2022 - 2024)

Historic Debt to Equity for HeartSciences (HSCS) over the last 3 years, with Q4 2024 value amounting to $0.01.

  • HeartSciences' Debt to Equity changed N/A to $0.01 in Q4 2024 from the same period last year, while for Oct 2024 it was $0.01, marking a year-over-year change of. This contributed to the annual value of $2.17 for FY2023, which is 39566.73% up from last year.
  • HeartSciences' Debt to Equity amounted to $0.01 in Q4 2024.
  • HeartSciences' 5-year Debt to Equity high stood at $2.17 for Q2 2023, and its period low was -$3.88 during Q1 2023.
  • Moreover, its 3-year median value for Debt to Equity was $0.01 (2024), whereas its average is -$0.42.
  • Data for HeartSciences' Debt to Equity shows a peak YoY increase of 39566.73% (in 2023) and a maximum YoY decrease of 37900.6% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows HeartSciences' Debt to Equity stood at $0.34 in 2022, then crashed by 379.01% to -$0.96 in 2023, then surged by 101.28% to $0.01 in 2024.
  • Its Debt to Equity stands at $0.01 for Q4 2024, versus $0.08 for Q3 2024 and -$0.96 for Q3 2023.